Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments
Sensorion and EVEON are collaborating on the design and development of an injection system for…
January 31, 2023 - 3 minutes
hearing loss
Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial
Sensorion has announced that the first patient has been enrolled in its phase 2a proof…
January 3, 2023 - 3 minutes
Sensorion granted rare pediatric disease designation by FDA for lead therapy gene
Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric…
November 7, 2022 - 2 minutes
Sensorion gets go-ahead from France for trial of drug to prevent hearing loss
Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept…
October 24, 2022 - 3 minutes
Sensorion receives positive opinion from EMA for treatment of hearing loss
The European Medicines Agency (EMA) through its Committee for Orphan Medicinal Products (COMP) has adopted…
September 12, 2022 - 3 minutes
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
July 22, 2022 - 7 minutes
Mogrify and Astellas to address sensorineural hearing loss
Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a…
July 5, 2022 - 2 minutes
Progress for hearing preservation trial after Australian approval granted
Approval has been granted by the Australian authorities to allow a French company to progress…
July 1, 2022 - 3 minutes
